Spotlight on the treatment of ALK-rearranged non-small-cell lung cancer.

dc.contributor.authorMamdani, Hirva
dc.contributor.authorJalal, Shadia I.
dc.contributor.departmentMedicine, School of Medicineen_US
dc.date.accessioned2019-07-05T14:31:53Z
dc.date.available2019-07-05T14:31:53Z
dc.date.issued2017-12
dc.identifier.citationMamdani, H., & Jalal, S. I. (2017). Spotlight on the treatment of ALK-rearranged non-small-cell lung cancer. Lung cancer management, 6(4), 125–128. doi:10.2217/lmt-2018-0004en_US
dc.identifier.urihttps://hdl.handle.net/1805/19847
dc.language.isoen_USen_US
dc.publisherFuture Medicineen_US
dc.relation.isversionof10.2217/lmt-2018-0004en_US
dc.relation.journalLung Cancer Managementen_US
dc.rightsPublisher Policyen_US
dc.sourcePMCen_US
dc.subjectALK rearrangementen_US
dc.subjectAlectiniben_US
dc.subjectBrigatiniben_US
dc.subjectCeritiniben_US
dc.subjectCrizotiniben_US
dc.subjectMolecularly targeted therapyen_US
dc.subjectNon-small-cell lung canceren_US
dc.titleSpotlight on the treatment of ALK-rearranged non-small-cell lung cancer.en_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
lmt-06-125.pdf
Size:
508.7 KB
Format:
Adobe Portable Document Format
Description:
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.99 KB
Format:
Item-specific license agreed upon to submission
Description: